Literature DB >> 7695607

The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors.

E F Adams1, B Petersen, T Lei, M Buchfelder, R Fahlbusch.   

Abstract

L-692,429 is a non-peptidyl GH secretagogue. We examined the effects of L-692,429 on cultured human pituitary tumors removed from patients with acromegaly. Dose-dependent stimulation of GH secretion was observed, with 1 mumol/L leading to 2 or 3-fold increases. Prolactin (PRL) secretion by a mixed somatotrophic-lactotrophic tumor was also stimulated. The effects of L-692,429 were abolished by phloretin and W7 but not Rp-cAMPS. Rate of phosphatidylinositol turnover was markedly increased up to 3-fold by L-692,429. These results show that L-692,429 increases hormone secretion by human pituitary cells via a protein kinase C and Ca2+ dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695607     DOI: 10.1006/bbrc.1995.1374

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  [Molecular analysis of the human "growth hormone secretagogue"-receptor].

Authors:  S Petersenn; M Penshorn; F U Beil; H M Schulte
Journal:  Med Klin (Munich)       Date:  1999-04-15

2.  Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.

Authors:  E Arvat; L Di Vito; F Lanfranco; F Broglio; R Giordano; A Benso; G P Muccioli; R Deghenghi; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

3.  Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.

Authors:  S Grottoli; E Arvat; C Gauna; B Maccagno; J Ramunni; R Giordano; M Maccario; R Deghenghi; E Ghigo
Journal:  Pituitary       Date:  1999-11       Impact factor: 4.107

4.  Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor.

Authors:  Sabata Pierno; Annamaria De Luca; Jean-François Desaphy; Bodvael Fraysse; Antonella Liantonio; Maria Paola Didonna; Marcello Lograno; Daniela Cocchi; Roy G Smith; Diana Conte Camerino
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

5.  Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women.

Authors:  E Arvat; B Maccagno; J Ramunni; F Broglio; F Lanfranco; R Giordano; A Benso; R Deghenghi; E Ghigo
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

6.  Relationship between GHRP-6 and TPA in the regulation of growth hormone secretion by human pituitary somatotrophinomas.

Authors:  Q Liu; T Lei; E F Adams; M Buchfedlder; R Fahlbusch
Journal:  J Tongji Med Univ       Date:  1997

7.  Ghrelin in central neurons.

Authors:  F Ferrini; C Salio; L Lossi; A Merighi
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

8.  GHS-R1a constitutive activity and its physiological relevance.

Authors:  Yves Mear; Alain Enjalbert; Sylvie Thirion
Journal:  Front Neurosci       Date:  2013-05-29       Impact factor: 4.677

Review 9.  The growth hormone secretagogue receptor: its intracellular signaling and regulation.

Authors:  Yue Yin; Yin Li; Weizhen Zhang
Journal:  Int J Mol Sci       Date:  2014-03-19       Impact factor: 5.923

10.  Ghrelin accelerates synapse formation and activity development in cultured cortical networks.

Authors:  Irina I Stoyanova; Joost le Feber
Journal:  BMC Neurosci       Date:  2014-04-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.